Отказ от этических правил делает Китай лидером CRISPR-технологий
Posted by btwatson on January 28, 2018 2:51 am
Tags:
Categories:
Crispr
Отказ от этических правил делает Китай лидером CRISPR-технологий
ST180123 004 Отказ от этических правил делает Китай лидером CRISPR-технологий
Crispr News
-
Crispr Genomic Cure Market: Moving Towards a Brighter Future | An ... - Digital JournalOctober 3, 2023
-
Regeneron and Intellia Announce Expanded Research ... - Bluefield Daily TelegraphOctober 3, 2023
-
Repare Therapeutics to Host Conference Call and Webcast to ... - InvestorsObserverOctober 3, 2023
-
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately ... - The Motley FoolOctober 3, 2023
-
Genome Engineering Market Research Report With Qualitative and ... - Digital JournalOctober 3, 2023
-
Sharper and Smaller – Tiny CRISPR Tool Could Help Shred Viruses - SciTechDailyOctober 3, 2023
-
Emerging Players and Innovative Technologies Transform the Landscape of Allogeneic CAR Cell Therapy Market - Yahoo FinanceOctober 2, 2023
-
5 FDA decisions to watch in the fourth quarter - BioPharma DiveOctober 2, 2023
-
Art imitates science - ASBMB TodayOctober 2, 2023
-
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - NasdaqOctober 2, 2023
-
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - The Motley FoolOctober 2, 2023
-
Readout Newsletter: Biotech news, J&J TB drug, Nobel winners - STATOctober 2, 2023
-
Rare mutation may counteract “Alzheimer’s gene” - FreethinkOctober 2, 2023
-
What we heard at World Agri-Tech and Future Food-Tech in London - AgFunderNewsOctober 2, 2023
-
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation - The Motley FoolOctober 2, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.